Gilead recalls 2 lots of COVID-19 drug Veklury after finding glass particulates in vials

Gilead Sciences' surprise blockbuster Veklury has braved its share of efficacy critiques. Now, the drug has run up against a manufacturing glitch.

Gilead is recalling two lots of the COVID-19 antiviral Veklury, also known as remdesivir, after a customer complaint flagged the presence of glass particulates. Gilead confirmed the complaint through its own investigation, the company said Friday.